Furthermore, the differential impact of anti-TNF treatment on INF-γ levels in Crohn’s disease versus ulcerative colitis, and the unique increase in memory CD8+ Tc2 cells in non-responders with CD, distinguishes our work. This evidence concerns the gene CD8A and Crohn disease.